Related Experiment Videos
Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in
Jinquan Bao1, Lingling Wu2, Wenqiang Zhao1
1The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous, China.
Background:
Osteoarthritis (OA) is a degenerative joint disease with complex molecular mechanisms. There is an interplay between programmed cell death (PCD) and extracellular matrix (ECM) in inflammatory diseases. This study aimed to identify a key PCD/ECM-related gene involved in OA pathogenesis through multi-omics analysis.
Methods:
RNA-seq data of OA synovial tissue from the GEO databases were analyzed. Weighted gene co-expression network analysis (WGCNA), differential expression analysis, cross analysis, and protein-protein interaction (PPI) network were used to identify key PCD/ECM-related genes in OA. Regulatory networks were predicted using miRDB, TargetScan, and miRWalk databases, and transcription factor binding was analyzed using JASPAR and FIMO. The role of MSR1 in OA progression was investigated by establishing an IL-1β-induced in vitro OA cell model.
Results:
We identified 517 genes associated with OA that were enriched in immune and developmental pathways. Differential expression analysis and cross-analysis revealed 24 OA-associated PCD- and ECM-related genes. MSR1 was identified as the key candidate via PPI network analysis. In both the training and validation sets, MSR1 expression was higher in OA samples than in healthy samples, with an AUC value greater than 0.7. MSR1 expression was positively correlated with key immune populations and microenvironment scores, suggesting a role for MSR1 in OA pathogenesis through immune modulation. In addition, molecular docking identified hesperidin as a high-affinity MSR1-binding compound with favorable interaction stability. In vitro experiments demonstrated that MSR1 was upregulated in IL-1β-induced OA-like chondrocytes and promoted apoptosis, extracellular matrix degradation, and NF-κB pathway activation.
Conclusion:
This study highlights PCD/ECM-related gene MSR1 as a central regulator of OA pathogenesis and proposes hesperidin as a potential therapeutic agent. The integrative approach provides a framework for understanding OA mechanisms and drug discovery.
Insights
Osteoarthritis involves programmed cell death and extracellular matrix changes. This study identifies MSR1 as a key gene in OA pathogenesis, suggesting hesperidin as a potential treatment.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with complex molecular underpinnings.
- Programmed cell death (PCD) and extracellular matrix (ECM) remodeling are implicated in OA pathogenesis.
- Identifying key genes in OA is crucial for understanding disease mechanisms.
Purpose of the Study:
- To identify a key programmed cell death/extracellular matrix-related gene in osteoarthritis (OA) pathogenesis.
- To investigate the role of the identified gene in OA progression.
- To explore potential therapeutic agents for OA.
Main Methods:
- Multi-omics analysis including RNA-seq and weighted gene co-expression network analysis (WGCNA).
- Differential expression analysis, protein-protein interaction (PPI) network construction, and regulatory network prediction.
- In vitro studies using an IL-1β-induced OA cell model and molecular docking for drug discovery.
Main Results:
- MSR1 was identified as a key OA-associated PCD/ECM-related gene.
- MSR1 expression is elevated in OA tissues and correlates with immune cell populations.
- In vitro, MSR1 promotes chondrocyte apoptosis, ECM degradation, and NF-κB pathway activation; hesperidin shows high-affinity binding to MSR1.
Conclusions:
- MSR1 is a central regulator in osteoarthritis pathogenesis, involving programmed cell death and extracellular matrix.
- MSR1's role in immune modulation offers insights into OA mechanisms.
- Hesperidin is proposed as a potential therapeutic agent for OA targeting MSR1.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Mesenchymal Stem Cells
MAPK Signaling Cascades
Osteoclasts in Bone Remodeling
The JAK-STAT Signaling Pathway